Controlling hospital-acquired infection due to carbapenem-resistant enterobacteriaceae (CRE)

Mitchell J. Schwaber*, Yehuda Carmeli, Stephan Harbarth

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

2 Scopus citations

Abstract

CRE impede effective therapy of patients with Gram-negative infections. They affect patients with poor functional status, prolonged hospital stay and multiple exposures to different antibiotic agents. Detecting carbapenemase-mediated carbapenem resistance is a challenge for many microbiology laboratories using automated susceptibility testing systems. To prevent nosocomial and community transmission of CRE, we recommend strict infection control measures-including contact isolation, cohorting of carriers, and dedicated staffing-alongside active surveillance of patients at risk for carriage. Little is known regarding the added value of antibiotic stewardship interventions to control epidemic or endemic transmission of CRE.

Original languageEnglish
Title of host publicationAntibiotic Policies
Subtitle of host publicationControlling Hospital Acquired Infection
PublisherSpringer New York
Pages105-115
Number of pages11
Volume9781441917348
ISBN (Electronic)9781441917348
ISBN (Print)1441917330, 9781441917331
DOIs
StatePublished - 1 Dec 2012
Externally publishedYes

Keywords

  • Acinetobacter
  • Antibiotic resistance
  • KPC
  • Metallo beta-lactamase
  • OXA
  • Pseudomonas

Fingerprint

Dive into the research topics of 'Controlling hospital-acquired infection due to carbapenem-resistant enterobacteriaceae (CRE)'. Together they form a unique fingerprint.

Cite this